Leapfrog ordered to remove safety grade for 5 Tenet hospitals / Fierce
fiercehealthcare - A federal judge said a 2024 methodology update that adjusted the weighting of safety measures inputted for nonparticipating hospitals was "deceptive and unfair" under Florida law. Leapfrog plans to appeal, but said it will be making broader changes in rat…
#healthcare #publichealth #governmentpolicy #hospitaloperations #healthcarefinance
Tuesday, March 10, 2026, 1:24 pm / permalink 20479 / 3 stories in 19 hrs
Effects of daily multivitamin–multimineral and cocoa extract supplementation on epigenetic aging clocks in the COSMOS randomized clinical trial / Nature
Sidong Li / nature - Nature Medicine, Published online: 09 March 2026; doi:10.1038/s41591-026-04239-3In a prespecified ancillary analysis of the COSMOS randomized trial, supplementation with daily multivitamins, but not with cocoa extract, over the course of 2 years decreased…
#healthcare #publichealth #researchfunding
Monday, March 9, 2026, 6:24 pm / permalink 20417 / 4 stories in 38 hrs
White House autism briefing linked to swift shifts in prescribing patterns / Medical Express
medicalxpress - A White House briefing in September 2025 that raised concerns about acetaminophen use during pregnancy and promoted the drug leucovorin as a potential autism treatment was followed by sharp changes in how doctors prescribed those medications nationwide, a…
#healthcare #pharmaceuticals #publichealth #governmentpolicy #infanthealth #hospitaloperations
Monday, March 9, 2026, 12:22 am / permalink 20354 / 2 stories in 2 days
MUSC Health acquires South Carolina's largest multispecialty practice for $111M / Fierce
fiercehealthcare - The deal, effective March 3, includes 126 physicians and advanced practitioners, expanding the academic system's primary care capacity.
#healthcare #mergersandacquisitions #corporatetakeover #hospitaloperations #healthcarefinance
Monday, March 9, 2026, 12:22 am / permalink 20353 / 4 stories in 2 days
Eli Lilly's new program aims to boost employer coverage of GLP-1s / Endpoints
Shelby Livingston / endpoints - With insurance coverage of weight loss medications stalled, Eli Lilly has developed a program to give employers another way to pay for their workers' GLP-1 treatments. The pharma giant on Thursday announced the launch of ...
#obesity #healthcare #pharmaceuticals #drugpricing #elililly #weightloss #healthcarefinance
Saturday, March 7, 2026, 10:21 pm / permalink 20341 / 16 stories in 3 days
Patients with multiple chronic diseases are a looming threat to health systems' financials: Vizient / Fierce
fiercehealthcare - A recent claims data analysis shows the 11% of people with multiple chronic conditions are behind 52% of inpatient admissions and about a third of outpatient visits. Their projected increases and unfavorable payer mix spell trouble for health systems' bot…
#healthcare #publichealth #hospitaloperations #healthcarefinance
Saturday, March 7, 2026, 10:21 pm / permalink 20340 / 2 stories in 3 days
How springing forward to daylight saving time could affect your health / Medical Express
medicalxpress - Most of America "springs forward" Sunday for daylight saving time. Losing that hour of sleep can do more than leave you tired and cranky the next day; it also could harm your health.
#healthcare #publichealth #behavioralhealth
Saturday, March 7, 2026, 6:21 pm / permalink 20336 / 8 stories in 3 days
Elizabeth McKenna: New Cancer Grand Challenges Teams Announced / OncoDaily
oncodaily - Elizabeth McKenna, Executive Editor of Cancer Discovery, shared a post on X: “The new Cancer Grand Challenges teams have just been announced! Read about the teams tackling cancer avoidance, mechanisms […]
#healthcare #biotech #drugdevelopment #oncology #healthcarefinance #cancerresearch #researchfunding
Saturday, March 7, 2026, 11:22 am / permalink 20326 / 67 stories in 3 days
ASCO GU 2026 Highlights: Belzutifan + Lenvatinib and Pembrolizumab in RCC – IUCS / OncoDaily
oncodaily - International Urology Cancer Summit shared a post on LinkedIn: “IUCS Journal Club – Highlights from ASCO GU 2026: Targeting HIF-2α in RCC. This Journal Club session reviews the data from […]
#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology
Saturday, March 7, 2026, 9:22 am / permalink 20321 / 3 stories in 3 days
CART19-BE-02 trial: From Bench to Bedside and Beyond – Resonance / OncoDaily
oncodaily - ALRCaN presents “CART19-BE-02 trial: From Bench to Bedside and Beyond—Implementing a Hospital-Based CAR T Program and Integrating It into the Spanish NHS” with Dr. Valentín Ortiz-Maldonado. “Dear friends and colleagues, […]
#healthcare #publichealth #governmentpolicy #healthcarefinance #infectiousdisease
Saturday, March 7, 2026, 2:22 am / permalink 20317 / 4 stories in 4 days
Telehealth growth hasn’t increased rural behavioral healthcare access: Study / Beckers
Giles Bruce / beckershospitalreview - The rise in telemedicine over the past several years hasn’t translated to more behavioral healthcare access in rural areas, according to a March 5 study in JAMA Network Open. Researchers from Boston-based Harvard Medical School and Providence, R.I.-based …
#healthcare #publichealth #governmentpolicy #digitalhealth #behavioralhealth #healthcarefinance
Saturday, March 7, 2026, 1:22 am / permalink 20316 / 5 stories in 4 days
New FDA bonus pilot to address 'workforce challenges' / Endpoints
Max Bayer / endpoints - A new bonus pilot program meant to reward fast-working FDA reviewers will be funded in part by money from industry user fees, the first details on how Commissioner Marty Makary plans to finance the incentive ...
#healthcare #pharmaceuticals #governmentpolicy #biotech #drugdevelopment #fda #healthcarefinance
Saturday, March 7, 2026, 12:23 am / permalink 20312 / 2 stories in 4 days
CVS Health, Google Cloud to launch healthcare engagement platform / Beckers
Naomi Diaz / beckershospitalreview - CVS Health is partnering with Google Cloud to develop an AI-powered consumer engagement platform as part of a broader effort to reshape how patients interact with the healthcare system. In a March 5 news release, the company announced a partnership with G…
Saturday, March 7, 2026, 12:23 am / permalink 20311 / 5 stories in 4 days
New AI tool predicts best pancreatic cancer treatment / Medical Express
medicalxpress - A new tool co-developed by investigators from Cedars-Sinai Health Sciences University can predict which of two available chemotherapy options for pancreatic cancer would be more effective for an individual patient.
#healthcare #biotech #digitalhealth #medicaldevices #oncology #pancreaticcancer
Saturday, March 7, 2026, 12:23 am / permalink 20310 / 3 stories in 4 days
FDA lifts hold on Intellia trial / Beckers
Ella Jeffries / beckershospitalreview - The FDA has lifted a clinical hold on Intellia Therapeutics’ phase 3 Magnitude trial of nexiguran ziclumeran, or nex-z. The trial was paused Oct. 29 after a patient developed grade 4 liver transaminase elevations and elevated bilirubin following a Sept. 3…
#healthcare #pharmaceuticals #biotech #drugdevelopment #fda
Saturday, March 7, 2026, 12:23 am / permalink 20309 / 2 stories in 4 days
Optum Rx, Caremark making ‘significant progress’ in settlement talks with FTC / Healthcare Dive
Rebecca Pifer Parduhn / healthcaredive - It’s looking increasingly likely that the UnitedHealth and CVS drug middlemen will also make peace with federal regulators, after Cigna agreed to a sweeping settlement in the insulin lawsuit last month.
#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy #healthcarefinance
Saturday, March 7, 2026, 12:23 am / permalink 20308 / 3 stories in 4 days
Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology / MedCity
Frank Vinluan / medcitynews - Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If Moderna’s full financial payout to the companies is reache…
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #healthcarefinance #infectiousdisease
Saturday, March 7, 2026, 12:22 am / permalink 20307 / 3 stories in 4 days
Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma / MedCity
Frank Vinluan / medcitynews - Day One Biopharmaceuticals is Servier’s biggest acquisition yet, topping the $2.4 billion it paid to buy Shire’s cancer business in 2018. Day One markets Ojemda, approved for treating pediatric low-grade glioma, the most common type of brain cancer in chi…
#healthcare #pharmaceuticals #biotech #mergersandacquisitions #drugdevelopment #oncology #healthcarefinance
Saturday, March 7, 2026, 12:22 am / permalink 20306 / 4 stories in 4 days
FDA vaccine chief to step down in April / Beckers
Ella Jeffries / beckershospitalreview - Vinay Prasad, MD, the FDA’s top regulator of vaccines and cell and gene therapies, will step down at the end of April, an agency spokesperson confirmed to Becker’s. Dr. Prasad joined the agency in 2025 on a one-year sabbatical from the University of Calif…
#healthcare #publichealth #governmentpolicy #biotech #drugdevelopment #fda #vaccinesafety #infectiousdisease
Friday, March 6, 2026, 6:23 pm / permalink 20292 / 3 stories in 4 days
Hospitals urge regulators to halt drugmakers’ expanded 340B data policies / Healthcare Dive
Emily Olsen / healthcaredive - The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more claims data on dispensed 340B drugs is onerous and unlawful.
#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy #hospitaloperations #healthcarefinance
Friday, March 6, 2026, 12:23 pm / permalink 20277 / 4 stories in 4 days